InsidersTradesSigma
Follow the Roivant Sciences Ltd. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Roivant Sciences Ltd. has logged 431 insider filings. Market capitalisation: €25.1bn. The latest transaction was reported on 28 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Venker Eric. The full history is openly available.
431
Insider Decl.
n/a
Thresholds
€20m
3 ops.
Buy Volume
€632m
86 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Roivant Sciences Ltd. Strong Buy (bullish), based on 11 analysts. Average price target: US$41.82.
36Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,834 of 29,020 companies
42.3
score / 100
Value28
Quality56
FCF yld-3.0%
Earn yld-1.2%
EV/EBITDA·
ROE-8.5%
Gross mgn84%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
Declarations431 total
200,000 shares@ US$35.7354CommonSEC144:0001965301-26-000133
13,909 shares@ US$36.840.0020% mcap0.7% of flowCommon SharesSEC:0001140361-26-034238:0
144,756 shares@ US$36.47520.020% mcap7.3% of flowCommonSEC144:0001950047-26-008512
172,899 shares@ US$3.850.0025% mcap0.6% of flowCommon SharesSEC:0001140361-26-034066:0
172,899 shares@ US$37.170.024% mcap5.6% of flowCommon SharesSEC:0001140361-26-034066:1
17,519 shares@ US$3.850.0003% mcap0.1% of flowCommon SharesSEC:0001140361-26-034066:2
17,519 shares@ US$37.300.0025% mcap0.6% of flowCommon SharesSEC:0001140361-26-034066:3
144,756 shares@ US$3.850.0021% mcap0.5% of flowCommon SharesSEC:0001140361-26-034066:4
144,756 shares@ US$36.480.020% mcap4.5% of flowCommon SharesSEC:0001140361-26-034066:5
17,519 shares@ US$37.29710.0025% mcap1.0% of flowCommonSEC144:0001950047-26-008467
172,899 shares@ US$37.16830.025% mcap9.8% of flowCommonSEC144:0001950047-26-008392
136,942 shares@ US$36.72510.019% mcap8.5% of flowCommonSEC144:0001950047-26-008341
243,177 shares@ US$3.850.0036% mcap0.9% of flowCommon SharesSEC:0001140361-26-033637:0
243,177 shares@ US$36.230.034% mcap8.7% of flowCommon SharesSEC:0001140361-26-033637:1
284,707 shares@ US$3.850.0042% mcap1.1% of flowCommon SharesSEC:0001140361-26-033637:2
284,707 shares@ US$36.250.039% mcap10.1% of flowCommon SharesSEC:0001140361-26-033637:3
105,141 shares@ US$3.850.0015% mcap0.4% of flowCommon SharesSEC:0001140361-26-033637:4
105,141 shares@ US$36.590.015% mcap3.8% of flowCommon SharesSEC:0001140361-26-033637:5
31,801 shares@ US$3.850.0005% mcap0.1% of flowCommon SharesSEC:0001140361-26-033637:6
31,801 shares@ US$37.180.0045% mcap1.2% of flowCommon SharesSEC:0001140361-26-033637:7
284,707 shares@ US$36.24980.039% mcap19.1% of flowCommonSEC144:0001950047-26-008265
243,177 shares@ US$36.22780.034% mcap20.3% of flowCommonSEC144:0001950047-26-008125
200,000 shares@ US$34.950.028% mcap10.4% of flowCommon SharesSEC:0001140361-26-030107:1
200,000 shares@ US$3.850.0031% mcap1.1% of flowCommon SharesSEC:0001140361-26-030107:0
200,000 shares@ US$34.94960.028% mcap11.7% of flowCommonSEC144:0001965301-26-000094
25 of 431 declarations
About Roivant Sciences Ltd.
Roivant Sciences Ltd. is a biopharmaceutical company focused on developing innovative medicines to address unmet medical needs. It employs a technology-driven approach to accelerate the drug discovery and development process.